anthonyyazdaniml/gliner-biomed-curated-corpus huggingface dataset:
The primary aim is to perform a pilot study to gain information toward the implementation of a larger prospective study that will compare the performance of Cologuard with the gold-standard colonoscopy in identifying advanced adenomas and colorectal cancers in LS. Data regarding rate of consent, and adherence to the protocol will be recorded. Since patients with known genetic predisposition to cancers tend to view screening tests more positively than the general population, a second aim of the study is to evaluate patient satisfaction with bowel preparation, colonoscopies, and Cologuard testing. Up to 90 individuals with genetically confirmed LS will be recruited via Geisinger's HRC to complete a goal of 90 Cologuard studies. Upon enrollment, Cologuard will be ordered by the study team at no cost to the subject and will be completed according to the standard instructions for use. Results will be securely obtained and blinded until the time of data analysis. Subjects will undergo colonoscopy as part of their routine HRC visit. Results from the colonoscopy (and biopsy as indicated) will be retrieved from the Electronic Health Record (EHR) and documented in a research-associated spreadsheet. If repeat colonoscopy is clinically indicated, repeat Cologuard may be completed if the subject meets inclusion criteria.
PURPOSE: This study investigated imaging biomarkers derived from PSMA-PET acquired pre- and post-metastasis-directed therapy (MDT) to predict 2-year metastasis-free survival (MFS), which provides valuable early response assessment to improve patient outcomes.
MATERIALS/METHODS: An international cohort of 117 oligometastatic castration-sensitive prostate cancer (omCSPC) patients, comprising 34 from John Hopkins Hospital (JHH) and 83 from Baskent University (BU), were treated with stereotactic ablative radiation therapy (SABR) MDT with both pre- and post-MDT PSMA-PET/CT scans acquired. PET radiomic features were analyzed from a CT-PET fusion defined gross tumor volume ((GTV) or zone 1), and a 5 mm expansion ring area outside the GTV (zone 2). A total of 1748 PET radiomic features were extracted from these zones. The six most significant features selected using the Chi2 method, along with five clinical parameters (age, Gleason score, number of total lesions, untreated lesions, and pre-MDT prostate-specific antigen (PSA)) were extracted as inputs to the models. Various machine learning models, including Random Forest, Decision Tree, Support Vector Machine, and Naïve Bayesian, were employed for 2-year MFS prediction and tested using leave-one-out and cross-institution validation.
RESULTS: Six radiomic features, including Total Energy, Entropy, and Standard Deviation from pre-PSMA-PET zone 1, Total Energy and Contrast from post-PSMA-PET zone 1, and Entropy from pre-PSMA-PET zone 2, along with five clinical parameters were selected for predicting 2-year MFS. In a leave-one-out test with all the patients, random forest achieved an accuracy of 80 % and an AUC of 0.82 in predicting 2-year MFS. In cross-institution validation, the model correctly predicted 2-year MFS events with an accuracy of 75 % and an AUC of 0.77 for patients from JHH, and an accuracy of 78 % and an AUC of 0.80 for BU patients, respectively.
CONCLUSION: Our study demonstrated the promise of using pre- and post-MDT PSMA-PET-based imaging biomarkers for MFS prediction for omCSPC patients.
In Part A, 10 subjects will receive MW151 in an open label evaluation. At least 5 of these subjects will be male. For each subject, safety and tolerability data for the first 24 hours will be reviewed prior to the continuation of dosing. Subjects will also be evaluated for safety during week 1, during week 2, and at week 4. Once the data from Part A have been reviewed by the Safety Monitoring Committee (SMC) for males and females, an additional 30 subjects will be recruited to Part B. These subjects will also receive open label MW-151.

In both parts A and B subjects will take study drug (males), or the first daily dose of study drug (females) before WBRT which will be administered once a day (3Gy), five days a week (Monday to Friday) for two weeks, for total of ten treatments and 30 Gy.
Some patients develop persistent eye pain after refractive surgery, but factors that cause or sustain pain are unknown. We tested whether tear proteins of patients with pain 3 months after surgery differ from those of patients without pain. Patients undergoing refractive surgery (laser in situ keratomileusis or photorefractive keratectomy ) were recruited from 2 clinics, and tears were collected 3 months after surgery. Participants rated their eye pain using a numerical rating scale (NRS, 0-10; no pain-worst pain) at baseline, 1 day, and 3 months after surgery. Using tandem mass tag proteomic analysis, we examined tears from patients with pain [NRS ≥ 3 at 3 months (n = 16)] and patients with no pain [NRS ≤ 1 at 3 months (n = 32)] after surgery. A subset of proteins (83 of 2748 detected, 3.0%) were associated with pain 3 months after surgery. High-dimensional statistical models showed that the magnitude of differential expression was not the only important factor in classifying tear samples from pain patients. Models utilizing 3 or 4 proteins had better classification performance than single proteins and represented differences in both directions (higher or lower in pain). Thus, patterns of protein differences may serve as biomarkers of postsurgical eye pain as well as potential therapeutic targets.
A hygiene tissue to be used for cleaning and caring of the skin and the urogenital area, simultaneously delivers lactic acid producing bacteria, thereby establishing and maintaining a healthy microbial flora in these areas. The hygiene tissue is impregnated with a composition including a lactic acid producing bacterium/bacteria suspended in a lipid and optionally additional components. Encapsulating the lactic acid producing bacterium in a lipid provides a moisturefree environment enhancing the survival of the bacterium and keeping the bacterium fit for growth after delivery to the skin. By this approach, hygiene tissues, including lactic acid producing bacteria can be stored for long time periods. Also, the hygiene tissue improves the efficiency of transfer of the lactic acid producing bacterium to the skin and urogenital area. In addition, the lipid provides a cleaning function, so that the skin is cleaned simultaneously as the lactic acid bacteria is delivered.
The present disclosure provides feed additive compositions and related methods for the treatment and prevention of campylobacter infection. The feed additive compositions herein can include a microbial fermentate product. The microbial fermentate product can be present in the feed additive composition in an amount effective to produce an inhibitory effect against Campylobacter bacteria in an animal. The Campylobacter bacteria can include several species, including Campylobacter jejuni or Campylobacter helveticus. The feed additive compositions herein can produce an inhibitory effect that includes a direct or indirect inhibition of growth of Campylobacter bacteria, where the inhibitory effect against Campylobacter bacteria results in one or more beneficial effects for the animal. Other aspects are also included herein.
The process of age-related changes involves some kind of degenerative, gradual changes which are irreversible such as degradation of activity of cells and loss of physical adaptability. According to age-related changes such as changes in balance are specifically begins near the age 45 years-old, physical characteristics such as (flexibility, strength, balance and coordination) and sensory systems are affected which ultimately increase the chances of falls in elderly individuals. Balance can be defined as the ability of a person to control their position within the limits of base of support. Pilates is an individualized-based and low-intermediate intensity exercise that can be easily performed by the elderly . Conventional balance exercises which have rehabilitative effect in reducing risk of falls and enhancing functional ability in elderly population. Conventional balance training comprises of four components which are flexibility exercises, strength training, postural control exercise and endurance training.The objective of the study IS to find out the effects of Pilates exercises on dynamic balance in elderly population. The Twenty-four participants will be recruited and divided into two equal groups randomly. The group A(n=12) will perform Pilates-based exercises protocol for 50- minutes with 10-minutes warm-up phase, 30-minutes training phase and 10-minutes for cool-down phase, thrice a week for four week and the group B(n=12) will receive Conventional balance training exercises for 50-minutes, thrice a week for four weeks. Outcome measures will be were TUG and SPPB before and after the trial and the outcomes will be compared before and end of four weeks treatment protocol. Data will be analyze by SPSS version 21. Independent sample t- test and paired sample t-test will be utilize to compare and evaluate the effects of both approaches.
Urinary tract infections (UTI) are the most common type of human bacterial disease, prompting more than 10 million physician office visits annually at a healthcare cost of over $1 billion dollars. Treatment of UTI is typically empiric or culture-driven antibiotics which are associated with ever increasing bacterial resistance. Over the last decade, The Human Microbiome Project has established that even 'culture-negative' urine represents a diverse ecosystem of bacteria. Despite broad use of antibiotics to cure disease for the past 90 years, the broader impact of antibiotics on typical flora are not well understood. Antibiotics are also commonly used as prophylaxis for surgical procedures in the urinary tract altering patient outcomes in unforeseen ways. Despite widespread utilization of antibiotics, the longitudinal impact on the dynamic intravesical environment remains completely unknown.

Dysbiosis in the microbiome has been suggested as a causative agent in a wide range of disease: arthritis, metabolic disorders, neurologic disease, inflammatory bowel conditions, and cancer. Yet there remains a fundamental knowledge gap regarding the short and long-term effect of antibiotics on microbiota communities. Specifically within the urinary tract, variance in baseline commensal organisms have been associated with interstitial cystitis, overactive bladder, frequent symptomatic urinary tract infection and potentially cancer development. The study of microbiota reveal pathways and mechanisms that play important roles in immunological response and health but studies typically are limited to the gut.

To address this knowledge gap, the investigators plan a placebo controlled randomized trial to test the longitudinal impact of 10 days of trimethoprim-sulfamethoxazole on the urinary microbiome in healthy adults. Data collection for individual participants will persist for a period of 6 months. The investigators hypothesize antibiotic administration contributes to a rise in bacterial resistance and directly leads to urine microbiome dysbiosis. The investigators further hypothesize the urinary microbiome does not return to baseline, with loss of certain bacteria permanent during the study period. While the investigators' study is groundbreaking and novel, the feasibility of the investigators' experimental plan has been previously demonstrated in the study of the salivary and gut microbiome. Ultimately the investigators anticipate even a single course of antibiotic treatment may increase the risk of bacterial resistance and lead to long-lasting shifts in the urinary microbiome. If confirmed, this knowledge will directly influence clinical decision making in antibiotic selection, duration, and utility.
The primary outcome is the incidence of hypocalcemia among pregnant women in the first half of pregnancy. This study also has secondary objectives. The one is associating factors with calcium level. After getting the results of maternal calcium level, the normal calcium level group will be divided into 2 groups for receiving calcium 1 g/day and no receiving calcium supplement. Another with hypocalcemia group will be decided into 2 groups for receiving calcium 1 g/day and 2 g/day. The calcium level was collected again in the third trimester.
The present invention relates to a method for producing a mask pack cosmetic composition. The method comprises the following steps: collecting, sorting, and washing freshwater pearls; naturally drying the freshwater pearls at 20 to 40C without using a dryer; obtaining freshwater pearl powder by firstly and secondly pulverizing the dried freshwater pearls; enzymatically decomposing the freshwater pearl powder to be processed into gel-state freshwater pearl gel; and obtaining a pearl extract composition extracted from the freshwater pearl gel through vacuum low temperature extraction and distillation extraction. The vacuum low temperature extraction is performed for 1 to 2 hours at a temperature of 50 to 65C and at pressure of 0.06 Torr. Accordingly, a cosmetic product pearl extract is extracted from freshwater pearls by using vacuum low temperature extraction and distillation extraction. Compared to extraction using an organic extraction solvent or extraction at a high temperature or at high pressure, a loss of material intrinsic nutrients is minimized, and stability of materials can be ensured. Moreover, according to the present invention, skin can be protected by an antioxidant material.
The present invention relates to a health care product for assisting in reducing blood sugar and blood fat. The medicine of the present invention is composed of the following main components according to the weight proportion: 1 to 10 portions of ginseng and 90 to 100 portions of cassia bark. The preparing method comprises: step 1: after being dried, the ginseng is crushed and sieved to obtain powder; step 2: after being dried, the cassia bark is crushed and sieved to obtain powder; step 3: after being mixed, the powder is poured into capsules. The present invention has the advantages that medicine and food isogeny plants are used, the present invention is natural health care capsules which are safe and convenient to eat. The ginseng is sweet and a little bitter in taste, and is a little warm; the ginseng can greatly invigorate pneuma, and promote fluid production to quench thirst; the cassia bark is common food seasoning. Researches indicate that frequent eating of the cassia bark can have the functions of reducing blood sugar, triglyceride, low-density lipoprotein, total cholesterol, etc. for patients with type 2 diabetes. The capsule is developed according to theoretical science compatibility of traditional Chinese medicine, various prescription functions are mutually cooperated, and the therapeutic effect is more obvious. The capsule has health care functions for general people.
Objective: Given the significant economic, health care, and personal burden of acute and chronic wounds, we investigated the dose dependent wound healing mechanisms of two Avena sativa derived compounds: avenanthramide (AVN) and β-Glucan. Approach: We utilized a splinted excisional wound model that mimics human-like wound healing and performed subcutaneous AVN and β-Glucan injections in 15-week-old C57BL/6 mice. Histologic and immunohistochemical analysis was performed on the explanted scar tissue to assess changes in collagen architecture and cellular responses. Results: AVN and β-Glucan treatment provided therapeutic benefits at a 1% dose by weight in a phosphate-buffered saline vehicle, including accelerated healing time, beneficial cellular recruitment, and improved tissue architecture of healed scars. One percent AVN treatment promoted an extracellular matrix (ECM) architecture similar to unwounded skin, with shorter, more randomly aligned collagen fibers and reduced inflammatory cell presence in the healed tissue. One percent β-Glucan treatment promoted a tissue architecture characterized by long, thick bundles of collagen with increased blood vessel density. Innovation: AVN and β-Glucan have previously shown promise in promoting wound healing, although the therapeutic efficacies and mechanisms of these bioactive compounds remain incompletely understood. Furthermore, the healed ECM architecture of these wounds has not been characterized. Conclusions: AVN and β-Glucan accelerated wound closure compared to controls through distinct mechanisms. AVN-treated scars displayed a more regenerative tissue architecture with reduced inflammatory cell recruitment, while β-Glucan demonstrated increased angiogenesis with more highly aligned tissue architecture more indicative of fibrosis. A deeper understanding of the mechanisms driving healing in these two naturally derived therapeutics will be important for translation to human use.
The effectiveness of Risperidone for Extended-Release Injectable Suspension as an adjunct to treatment with lithium or valproate for the maintenance treatment of Bipolar Disorder was established in a multi-center, randomized, double-blind, placebo-controlled study of adult patients who met DSM-IV criteria for Bipolar Disorder Type I and who experienced at least 4 episodes of mood disorder requiring psychiatric/clinical intervention in the previous 12 months, including at least 2 episodes in the 6 months prior to the start of the study.

A total of 240 patients were treated during a 16-week open-label period with Risperidone for Extended-Release Injectable Suspension (starting dose of 25 mg, and titrated, if deemed clinically desirable, to 37.5 mg or 50 mg), as adjunctive therapy in addition to continuing their treatment as usual for their bipolar disorder, which consisted of mood stabilizers (primarily lithium and valproate), antidepressants, and/or anxiolytics. All oral antipsychotics were discontinued after the first three weeks of the initial Risperidone for Extended-Release Injectable Suspension injection. In the open-label phase, 124 (51.7%) were judged to be stable for at least the last 4 weeks and were randomized to double-blind treatment with either the same dose of Risperidone for Extended-Release Injectable Suspension or placebo in addition to continuing their treatment as usual and monitored for relapse during a 52-week period. The primary endpoint was time to relapse to any new mood episode (depression, mania, hypomania, or mixed).

Time to relapse was delayed in patients receiving adjunctive therapy with Risperidone for Extended-Release Injectable Suspension as compared to placebo. The relapse types were about half depressive and half manic or mixed episodes.
PURPOSE: Echocardiography is recommended as a first-line tool in the assessment of patients with shock. The current provision of echocardiography in critical care is poorly defined. The aims of this work were to evaluate the utilisation of echocardiography in patients presenting to critical care with shock, its impact on decision making, and adherence to governance guidelines.
METHODS: We conducted a prospective, multi-centre, observational study in 178 critical care units across the United Kingdom (UK) and Crown Dependencies, led by the UK's Trainee Research in Intensive Care Network. Consecutive adult patients (≥ 18 years) admitted with shock were followed up for 72 h to ascertain whether they received an echocardiogram, the nature of any scan performed, and its effect on critical treatment decision making.
RESULTS: 1015 patients with shock were included. An echocardiogram was performed on 545 (54%) patients within 72 h and 436 (43%) within 24 h of admission. Most scans were performed by the critical care team (n = 314, 58%). Echocardiography was reported to either reduce diagnostic uncertainty or change management in 291 (54%) cases. Patients with obstructive or cardiogenic shock had their management altered numerically more often by echocardiography (n = 15 [75%] and n = 100 [58%] respectively). Twenty-five percent of echocardiograms performed adhered to current national governance and image storage guidance.
CONCLUSION: Use of echocardiography in the assessment of patients with shock remains heterogenous. When echocardiography is used, it improves diagnostic certainty or changes management in most patients. Future research should explore barriers to increasing use of echocardiography in assessing patients presenting with shock.
The invention discloses a traditional Chinese medicine for treating ischialgia and lumbago. The traditional Chinese medicine is a medicament prepared from veronicastrum axillare. The preparation method disclosed by the invention comprises the following steps: recovering a complete stool of veronicastrum axillare in autumn; cleaning and cutting into 1-5cm of segments; airing until the moisture content is about 10%; putting into a pressure cooker to boil for 45 minutes, and then drying until the moisture content is about 7%, and crushing into 130-150 meshes of powder. The invention also discloses a traditional Chinese medicine composition for treating ischialgia and lumbago. The traditional Chinese medicine composition is prepared from the following medicaments in parts by weight: 50 parts of veronicastrum axillare, 20 parts of codonopsis pilosula, 30 parts of radix angelicae pubescentis, 30 parts of radix clematidis, 15 parts of angelica sinensis and 20 parts of huangmao (Chinese character). By taking the traditional Chinese medicine, the channels can be dredged, blood circulation can be improved, the ischialgia and lumbago symptoms can be quickly removed, the diseased tissue of the ischialgia can be repaired, the neuralgia root can be relived, and the traditional Chinese medicine can curve one time, and is free of toxic and side effects, and significant in effect on treatment of the ischialgia and the lumbago.